Elsevier

The Lancet

Volume 351, Issue 9113, 9 May 1998, Page 1430
The Lancet

Correspondence
Statins and fibrinogen

https://doi.org/10.1016/S0140-6736(98)26019-3Get rights and content

References (5)

  • AS Wierzbicki et al.

    Effect of atorvastatin on plasma fibrinogen

    Lancet

    (1998)
  • RG Bakker-Arkema et al.

    Efficacy and safety of a new HMG-CoA reductace inhibitor, atorvastatin, in patients with hypertriglyceridemia

    JAMA

    (1996)
There are more references available in the full text version of this article.

Cited by (56)

  • Anticoagulant Effects of Statins

    2004, Statins: Understanding Clinical Use
  • Dyslipidemia and the vulnerable plaque

    2002, Progress in Cardiovascular Diseases
View all citing articles on Scopus
View full text